Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 54 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

Dementia presents an escalating public health challenge worldwide. While traditional risk factors such as metabolic syndromes and lifestyle choices have been widely examined, growing evidence highlights the role of mental health conditions in the development of dementia. Our manuscript is a narrative review of peer-reviewed systematic reviews and meta-analyses examining the association between common psychiatric disorders, namely depression, bipolar disorder, anxiety, post traumatic stress disorder (PTSD), schizophrenia, and the onset of neurocognitive decline. Additional factors such as chronic stress, sleep disturbances, and exposure to traumatic life events are also considered. Proposed mechanisms include endocrine dysregulation, neuroinflammation, and altered immune responses. The review further explores how psychopharmacological interventions may influence cognitive outcomes later in life. These insights aim to enhance clinicians' ability to identify at-risk populations and inform preventive strategies.

Key findings

Why it matters

This narrative review examines associations between psychiatric disorders such as depression, anxiety and PTSD and later neurocognitive decline, and discusses possible mechanisms and psychopharmacological effects. It summarizes existing evidence and does not report a new treatment or cure.

Study details

How this study scored 54/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 12 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 4 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 1 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 52 of the 96 points it could be judged on, which is 54 of 100. Total 54 of 100.52 of the 96 points we could judge = 54 of 100

Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. Scored zero for sample size, effect reported and studied in people because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 52 of the 96 points we could judge it on, which is 54 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Cureus)
Journal's citation record 1 / 4 Cureus: journal h-index 131 (OpenAlex, 2026-10-29)
Study design 12 / 12 A meta-analysis pooling many studies
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 A review of other studies — randomisation is not credited here
Times cited 1 / 7 Cited 2 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 2 year(s) since 2026
Impact for its field and year 4 / 6 Cited 9.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Nada Al Zamil holds only 1 work(s), too few to judge a track record — left out of this score
Institution's track record 1 / 3 McGill University: institution h-index 1,373 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41728498)
Free to read 2 / 2 Free to read
Points 52 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 52 of the 96 points we could judge it on is 54 out of 100.
Total 54 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Sulais, A. A., & Zamil, N. A. (2026). From Anxiety, Depression to Major Neurocognitive Disorders: Exploring Their Association With the Risk Factors for Dementia. Cureus. https://doi.org/10.7759/cureus.101994

Vancouver

Sulais AA, Zamil NA. From Anxiety, Depression to Major Neurocognitive Disorders: Exploring Their Association With the Risk Factors for Dementia. Cureus. 2026. doi:10.7759/cureus.101994. PMID: 41728498.

BibTeX

@article{sulais2026-41728498,
  author  = {Sulais, Ali A and Zamil, Nada Al},
  title   = {{From Anxiety, Depression to Major Neurocognitive Disorders: Exploring Their Association With the Risk Factors for Dementia}},
  journal = {Cureus},
  year    = {2026},
  doi     = {10.7759/cureus.101994},
  pmid    = {41728498},
  url     = {https://doi.org/10.7759/cureus.101994}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Risk factors

Similar studies

More on Risk factors

See all studies in Risk factors →